Untangling knots between autophagic targets and candidate drugs, in cancer therapy

Area of Science:

• Molecular Biology
• Cell Biology
• Oncology

Background:

• Autophagy is a conserved lysosomal degradation pathway crucial in cellular homeostasis.
• Dysregulation of autophagy is implicated in various pathologies, notably cancer.
• Key autophagy-related genes (Atgs) and regulatory proteins influence cancer development.

Purpose of the Study:

• To review recent discoveries of small molecules modulating autophagy in cancer.
• To explore the dual role of autophagy (tumor-promoting and tumor-suppressing) in cancer cells.
• To identify potential therapeutic strategies targeting autophagy for cancer treatment.

Main Methods:

• Literature review of small molecules and chemical compounds affecting autophagy.
• Analysis of regulatory pathways involving oncogenes, tumor suppressors, and autophagy.
• Discussion of the link between autophagic targets and drug candidates.

Main Results:

• Small molecules can induce either pro-death or pro-survival autophagy.
• Autophagy's role in cancer is context-dependent, offering therapeutic opportunities.
• Specific molecular targets within autophagy pathways are being identified for drug development.

Conclusions:

• Targeting autophagy with small molecules presents a promising avenue for anti-cancer drug discovery.
• Understanding the intricate regulation of autophagy is key to developing effective cancer therapies.
• Further research into the interplay between autophagy and candidate drugs can illuminate new treatment strategies.